Literature DB >> 12435522

Topical immunotherapy: unapproved uses, dosages, or indications.

Elisabeth Higgins1, Anthony du Vivier.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12435522     DOI: 10.1016/s0738-081x(02)00272-9

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  6 in total

Review 1.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

Review 2.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

Review 3.  Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update.

Authors:  Thipprapai Mahasaksiri; Chaninan Kositkuljorn; Tanaporn Anuntrangsee; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2021-03-23       Impact factor: 4.162

4.  Combination therapy with cyclosporine and psoralen plus ultraviolet a in the patients with severe alopecia areata: a retrospective study with a self-controlled design.

Authors:  Kui Young Park; Woo Sun Jang; In Pyeong Son; Sun Young Choi; Moo Yeol Lee; Beom Joon Kim; Myeung Nam Kim; Byung In Ro
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

5.  A Case Report of Verruca Vulgaris on basis of Alopecia Areata Successfully Treated with Diphenylcyclopropenone.

Authors:  Tugba Kevser Uzuncakmak; Mahmut Can Koska; Ayşe Serap Karadağ; Necmettin Akdeniz
Journal:  Int J Trichology       Date:  2017 Jan-Mar

6.  Can the Cytokine Analysis of the Scales on Alopecic Patch Predict the Response to Diphenylcyclopropenone Treatment in Alopecia Areata Patients?

Authors:  Si Hyub Lee; Jong Hyuk Moon; Dae Hyun Ban; Ji Won Byun; Jeonghyun Shin; Gwang Seong Choi
Journal:  Ann Dermatol       Date:  2018-02-21       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.